These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27317955)

  • 21. Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.
    Wang L; Geng ZM; Song XG; Zhao YL; Noor H; Shi L; Liu QG
    Hepatogastroenterology; 2014 Jun; 61(132):927-32. PubMed ID: 26158143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma.
    Kang MJ; Jang JY; Chang J; Shin YC; Lee D; Kim HB; Kim SW
    World J Surg; 2016 Oct; 40(10):2451-9. PubMed ID: 27206402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New criteria of radical surgery and long-term outcomes of hilar cholangiocarcinoma management].
    Kovalenko YA; Vishnevsky VA; Chzhao AV; Zharikov YO
    Khirurgiia (Mosk); 2018; (8):4-11. PubMed ID: 30113586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of positive proximal margin after resection for hilar cholangiocarcinoma: An analysis of 42 cases.
    Öter V; Özer İ; Dalgıç T; Binarbaşı C; Ulaş M; Bostancı EB
    Turk J Gastroenterol; 2019 Jan; 30(1):88-94. PubMed ID: 30301710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Margin Status on Survival After Resection of Hilar Cholangiocarcinoma in the Modern Era of Adjuvant Therapies.
    Watson MD; Baimas-George MR; Passeri MJ; Sulzer JK; Baker EH; Ocuin LM; Martinie JB; Iannitti DA; Vrochides D
    Am Surg; 2021 Sep; 87(9):1496-1503. PubMed ID: 33345594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with survival in patients operated on for hilar cholangiocarcinoma with curative intention.
    Contreras T; Pacheco S; Briceño E; Martínez J; Guerra JF; Jarufe N
    Cir Cir; 2019; 87(5):508-515. PubMed ID: 31448794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
    Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
    Zhang XF; Squires MH; Bagante F; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    Ann Surg Oncol; 2018 May; 25(5):1140-1149. PubMed ID: 29470820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database.
    Jutric Z; Johnston WC; Hoen HM; Newell PH; Cassera MA; Hammill CW; Wolf RF; Hansen PD
    HPB (Oxford); 2016 Jan; 18(1):79-87. PubMed ID: 26776855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgery for hilar cholangiocarcinoma: the Leeds experience.
    Hidalgo E; Asthana S; Nishio H; Wyatt J; Toogood GJ; Prasad KR; Lodge JP
    Eur J Surg Oncol; 2008 Jul; 34(7):787-94. PubMed ID: 18036765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
    Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
    World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].
    Otto G; Thies J; Hoppe-Lotichius M; Bittinger F; Pitton MB; Hadian A
    Chirurg; 2004 Jan; 75(1):59-65. PubMed ID: 14740129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center.
    Ercolani G; Zanello M; Grazi GL; Cescon M; Ravaioli M; Del Gaudio M; Vetrone G; Cucchetti A; Brandi G; Ramacciato G; Pinna AD
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):329-37. PubMed ID: 20464563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
    Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
    Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reassessing the role of surgery in the elderly or chronically sick with proximal extrahepatic cholangiocarcinoma.
    Hue JJ; Sugumar K; Markt SC; Mohamed A; Selfridge JE; Bajor D; Rothermel LD; Hardacre JM; Ammori JB; Winter JM; Ocuin LM
    Surgery; 2021 Feb; 169(2):233-239. PubMed ID: 33087251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditional survival in patients with unresectable perihilar cholangiocarcinoma.
    Gaspersz MP; Buettner S; van Vugt JLA; Roos E; Coelen RJS; Vugts J; Belt EJ; de Jonge J; Polak WG; Willemssen FEJA; van Gulik TM; IJzermans JNM; Groot Koerkamp B
    HPB (Oxford); 2017 Nov; 19(11):966-971. PubMed ID: 28754366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined vascular resection and analysis of prognostic factors for hilar cholangiocarcinoma.
    Wang ST; Shen SL; Peng BG; Hua YP; Chen B; Kuang M; Li SQ; He Q; Liang LJ
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):626-32. PubMed ID: 26663011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.